Questionnaire

1. The ESC/EACTS guidelines for the prevention of thromboembolic events in AF:

2. The most robust intervention for avoiding stroke in patients with AF is:

3. Risk factors for bleeding in anticoagulated patients with AF include:

4. Upon achieving rhythm control in the patient with AF, it is recommended that anticoagulation be withdrawn:

5. For AF patients who are using warfarin and undergoing major surgery, it is recommended that:

6. Among risk factors for the development of AF, the most important are:

7. The time taken for warfarin to achieve adequate anticoagulation is:

8. A NOAC that is contraindicated for use in patients with eGFR <30ml/min/1.73m² is:

9. Patients with paroxysmal AF have fewer strokes and a lower incidence of systemic embolism than patients with persistent AF:

10. Off-label underdosing of NOACs reduces the risk of bleeding and all-cause mortality in patients with AF:

11. Compared with OAC for patients with AF, left atrial appendage occlusion has been associated with:

12. Cardiac biomarkers that are common in AF patients and are independently associated with increased risks of stroke and all-cause mortality are:

13. Compared with AF patients who received standard care, patients enrolled in the ABC integrated pathway of care demonstrated a reduced risk of:

14. To determine bleeding risk in anticoagulated AF patients, a validated tool is the:

15. Patient subgroups who do not respond well to warfarin anticoagulation include: